e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Risk assessment and prevention of complications in thoracic surgery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Anders Bugge (Oslo, Norway), Anders Bugge, May Brit Lund, Cathrine Brunborg, Steinar Solberg, Johny Kongerud
Source:
International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Session:
Risk assessment and prevention of complications in thoracic surgery
Session type:
Oral Presentation
Number:
1744
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anders Bugge (Oslo, Norway), Anders Bugge, May Brit Lund, Cathrine Brunborg, Steinar Solberg, Johny Kongerud. A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 1744
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Outcomes of radical treatment of early stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Prognostic value of preoperative C-reactive protein in resectable non-small cell lung cancer - 5-years prospective study
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Surgical treatmment non-small cell lung cancer in the elderly patients
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Risk factors for prolonged postoperative air leak-a retrospective analysis of 853 partial lung resections for non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
The effect of surgical specimen-derived phosphorus and lead concentrations in non-small cell lung cancer patients on disease course
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Is there a difference in response to first line chemotherapy related to age in patients with locally advanced or metastatic non-small lung cancer?
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
A phase III randomised trial testing chemotherapy in extensive small-cell lung cancer (SCLC)
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016
Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Is the lung cancer in elderly similar to lung cancer in younger patients?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Early versus late pulmonary rehabilitation (PR) following treatment for inoperable nonsmall cell lung cancer (NSCLC)
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept